Supposedly this funding will be sufficient to start a clinical trial for AMD but HBV will have to wait. Does anyone really believe this? I am still holding out for good TT-034 results but I have to say that recent events have dented my confidence in the cohort three outcomes. Fortunately, we won't have to wait too much long to see whether there will be agony or ecstasy when efficacy is announced.
- Forums
- ASX - By Stock
- BLT
- Updated listing price
Updated listing price, page-24
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some